Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03586648 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 6
- Study locations
NCT03586648: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT03586648 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 71 participants, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03586648, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.
Primary Outcome
Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more fa
Conditions Studied
Interventions
- DEVICE senofilcon A Multifocal
- DEVICE senofilcon A Sphere
- DEVICE etafilcon A Multifocal
- DEVICE etafilcon A Sphere
Study Locations (6)
Florida
- Dr. James E. Weber - Jacksonville
- Maitland Vision Center - Maitland
- Wayne Golden, OD - Sarasota
Ohio
- Western Reserve Vision Care - Beechwood
- Procare Vision Center - Granville
California
- Golden Optometric Group - Whittier
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2018-06-14 |
| Est. Completion | 2018-08-20 |
| Phase | NA |
What the finished NCT03586648 record still lists
NCT03586648 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 137-participant average among 20 other Visual Acuity trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 4 interventions - of which senofilcon A Multifocal is the first listed.
NCT03586648 lists 6 locations in 3 states (Florida, Ohio, California).
Frequently Asked Questions
What is clinical trial NCT03586648 about?
NCT03586648 is a clinical study titled "Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2". This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.
What is the current status of trial NCT03586648?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2018-06-14. Estimated completion is 2018-08-20.
What conditions does trial NCT03586648 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT03586648?
The interventions under investigation include: senofilcon A Multifocal (DEVICE), senofilcon A Sphere (DEVICE), etafilcon A Multifocal (DEVICE), etafilcon A Sphere (DEVICE).
Who is sponsoring clinical trial NCT03586648?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03586648 being conducted?
This trial has 6 study locations across California, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03586648's enrollment target sits among peer trials
71 15th of 20 higher than 5 of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
-
Clinical Evaluation of Manufacturing Processes for a Reusable Multifocal Optical Design in a Presbyopic Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI